About us
KNAX BEYOND THE CARE
Company Overview
KNAX is a bio-specialized company that develops diagnostic kits and pharmaceuticals which can be safely used by people around the world for accurate diagnosis and treatment of diseases.
We conduct research through a network formed with domestic and overseas research institutes to develop not only diagnostic kits for infectious diseases, cancers, and other diseases but also biopharmaceuticals at our HQ and company-affiliated research center in Hanam-si, Gyeonggi-do.
Everyone at KNAX strives to leap forward as a global company by implementing an innovative platform that can quickly and accurately diagnose diseases for a healthy life of humankind, and also by developing and launching new drugs and pharmaceuticals, as well as bioproducts such as diagnostic kits that can be safely used by people around the world.
Life Change with
KNAX
Everyone at KNAX strives to leap forward as a global company by implementing an innovative platform that can quickly and accurately diagnose diseases for a healthy life of humankind, and also by developing and launching new drugs and pharmaceuticals, as well as bioproducts such as diagnostic kits that can be safely used by people around the world.
Download Company Introduction
Core Values
P
Passion & Challenge
Challenge for successful business achievements with a passionate attitude and mind.
O
Open-mindedness
Create opportunities for new ideas by sharing thoughts and communicating open-mindedly.
C
Creativity & Innovation
Do not fear changes and discover new ideas and technologies to pioneer new values.
T
Trust & Professionalism
Build expertise as a trusted member of society through communication and cooperation.
VISION
With the goal of securing golden time for treatment through early diagnosis of diseases and rapid on-site diagnosis of infectious diseases, we will leap forward as a global bio company specializing in ideal and effective field-oriented diagnostics.
MISSION
To improve the quality of human life, we develop solutions that satisfy the diagnostics of diseases and optimal treatment time.
Recent Major Events
2021
  • 05Scheduled for GMP audit
  • 03ISO13485 audit completed
  • 01Development of COVID-19 and influenza A&B type combo RT-PCR kit completed(KNAX-SMART SARS-CoV-2, Influenza A&B Multiplex Real-time PCR Kit)
2020
  • 12COVID-19 and influenza A&B type combo rapid diagnostic kit launched
    (KNAX-SMART SARS-CoV-2, Influenza A&B Ag Combo)
  • 11

    COVID-19 antigen rapid diagnostic kit launched(KNAX-SMART SARS-CoV-2 Ag)

    COVID-19 antibody rapid diagnostic kit launched(KNAX-SMART SARS-CoV-2 IgM/IgG)

  • 08Company-affiliated research center established and recognized
  • 04Patent transfer agreement with Industry-Academic Cooperation Foundation of Chung-Ang University
  • 03

    Company name changed to KNAX Co., Ltd.

    MOU signed with Chem-Bio Diagnostic Technology Research Center of Chung-Ang University

2019
  • 08Strategic investment MOU of $10M signed with Xylonix
2000
  • 08Biogemex Co., Ltd. established